28513K.KS
SK Chemicals Co.,Ltd. [28513K.KS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
28513K.KS Stock Summary
Top 10 Correlated ETFs
28513K.KS
Top 10 Correlated Stocks
28513K.KS
In the News
28513K.KS Financial details
Company Rating
Buy
Market Cap
59.61B
Income
122.06B
Revenue
1794.44B
Book val./share
-
Cash/share
-
Dividend
1550
Dividend %
5.11%
Employees
1.22K
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
4.53
Forward P/E
-
PEG
-0.58
P/S
0.66
P/B
0.26
P/C
-
P/FCF
-2.08
Quick Ratio
-
Current Ratio
2.98
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
4.74K
EPS next Y
-
EPS next Q
-
EPS this Y
-52.93%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
100.65%
Revenue last 5Y
5.99%
Revenue Q/Q
56.58%
EPS Q/Q
-469.47%
-
-
-
-
SMA20
6.05%
SMA50
1.68%
SMA100
-1.34%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
6%
ROC
0.03%
Gross Margin
29%
Oper. Margin
6%
Profit Margin
7%
Payout
6%
Shs Outstand
38.98M
Shs Float
34.83M
-
-
-
-
Target Price
-
52W Range
26700.0-42500.0
52W High
-28.59%
52W Low
+13.67%
RSI
69
Rel Volume
-
Avg Volume
8.57K
Volume
Perf Week
3.58%
Perf Month
12.41%
Perf Quarter
-10.07%
Perf Half Y
-11.52%
-
-
-
-
Beta
1.0851
-
-
Volatility
408.58%, 887.16%
Prev Close
0.17%
Price
30350
Change
-1.14%
28513K.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 69.13K | 72.01K | 69.04K | 118.72K | 94.78K | |
| Net income per share | 304.67 | 253.35 | 510.12 | 21.06K | 9.91K | |
| Operating cash flow per share | 3.4K | 6.16K | 14.04K | 28.94K | -9.66K | |
| Free cash flow per share | -865.76 | -388.73 | 8.52K | 20.58K | -25.35K | |
| Cash per share | 9.13K | 13.76K | 24.25K | 116.45K | 89.11K | |
| Book value per share | 34.97K | 36.11K | 54.16K | 116.67K | 111.23K | |
| Tangible book value per share | 34.73K | 34.37K | 52.4K | 143.3K | 137.67K | |
| Share holders equity per share | 34.97K | 36.11K | 54.16K | 116.67K | 111.23K | |
| Interest debt per share | 47.87K | 58.71K | 41.66K | 28.25K | 38.47K | |
| Market cap | 481.79B | 570.83B | 3061.29B | 1564.8B | 717.97B | |
| Enterprise value | 1351.95B | 1517.25B | 3683.16B | 1795.91B | 1044.87B | |
| P/E ratio | 79.92 | 113.68 | 341.1 | 4.22 | 3.75 | |
| Price to sales ratio | 0.35 | 0.4 | 2.52 | 0.75 | 0.39 | |
| POCF ratio | 7.15 | 4.67 | 12.39 | 3.07 | -3.85 | |
| PFCF ratio | -28.13 | -74.09 | 20.43 | 4.32 | -1.47 | |
| P/B Ratio | 0.7 | 0.8 | 3.21 | 0.76 | 0.33 | |
| PTB ratio | 0.7 | 0.8 | 3.21 | 0.76 | 0.33 | |
| EV to sales | 0.99 | 1.06 | 3.03 | 0.86 | 0.57 | |
| Enterprise value over EBITDA | 9.88 | 8.98 | 17.42 | 2.81 | 3.07 | |
| EV to operating cash flow | 20.07 | 12.42 | 14.91 | 3.53 | -5.6 | |
| EV to free cash flow | -78.92 | -196.92 | 24.58 | 4.96 | -2.14 | |
| Earnings yield | 0.01 | 0.01 | 0 | 0.24 | 0.27 | |
| Free cash flow yield | -0.04 | -0.01 | 0.05 | 0.23 | -0.68 | |
| Debt to equity | 1.32 | 1.58 | 0.74 | 0.24 | 0.34 | |
| Debt to assets | 0.47 | 0.53 | 0.33 | 0.12 | 0.18 | |
| Net debt to EBITDA | 6.36 | 5.6 | 2.94 | 0.36 | 0.96 | |
| Current ratio | 1.21 | 1.1 | 1.43 | 2.56 | 2.38 | |
| Interest coverage | 1.44 | 2.41 | 4.36 | 52.38 | 14.91 | |
| Income quality | -4.1 | 24.32 | 0.97 | 1.9 | -0.81 | |
| Dividend Yield | 0 | 0.01 | 0 | 0.02 | 0.09 | |
| Payout ratio | 0 | 1.05 | 0.67 | 0.07 | 0.35 | |
| Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Research and developement to revenue | 0.04 | 0.05 | 0.05 | 0.04 | 0.05 | |
| Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | |
| Capex to operating cash flow | -1.25 | -1.06 | -0.39 | -0.29 | 1.62 | |
| Capex to revenue | -0.06 | -0.09 | -0.08 | -0.07 | -0.17 | |
| Capex to depreciation | -0.95 | -1.26 | -0.99 | -1.58 | -3.31 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 15.48K | 14.35K | 24.93K | 235.1K | 157.48K | |
| ROIC | -0.09 | 0.01 | 0.03 | 0.15 | 0.08 | |
| Return on tangible assets | 0 | 0 | 0 | 0.09 | 0.05 | |
| Graham Net | -36.82K | -42.21K | -24.15K | 64.03K | 49.94K | |
| Working capital | 122.86B | 73.16B | 277.61B | 1697.41B | 1459.87B | |
| Tangible asset value | 687.22B | 681.28B | 921.98B | 2522.32B | 2657.13B | |
| Net current asset value | -508.08B | -620.98B | -237.75B | 1395.16B | 1281.92B | |
| Invested capital | 1.32 | 1.58 | 0.74 | 0.24 | 0.34 | |
| Average receivables | 206.38B | 193.21B | 214.25B | 316.36B | 353.94B | |
| Average payables | 152.46B | 148.29B | 114.79B | 125.94B | 131.67B | |
| Average inventory | 309.61B | 329.78B | 291.77B | 301.11B | 416.03B | |
| Days sales outstanding | 53.9 | 47.17 | 73.33 | 67.89 | 63.7 | |
| Days payables outstanding | 50.23 | 48.35 | 35.36 | 50.8 | 28.62 | |
| Days of inventory on hand | 109.62 | 109.58 | 106.8 | 105.52 | 145.13 | |
| Receivables turnover | 6.77 | 7.74 | 4.98 | 5.38 | 5.73 | |
| Payables turnover | 7.27 | 7.55 | 10.32 | 7.19 | 12.75 | |
| Inventory turnover | 3.33 | 3.33 | 3.42 | 3.46 | 2.51 | |
| ROE | 0.01 | 0.01 | 0.01 | 0.18 | 0.09 | |
| Capex per share | -4.27K | -6.55K | -5.52K | -8.36K | -15.69K |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 22.55K | 24.73K | 18.96K | 23.1K | 0 | |
| Net income per share | 1.82K | 3.85K | 595.58 | -661 | 0 | |
| Operating cash flow per share | 1.69K | 1.34K | -4.45K | -5.11K | 0 | |
| Free cash flow per share | -2.38K | -4.14K | -12.79K | -12.36K | 0 | |
| Cash per share | 91.04K | 89.11K | 92.32K | 94.66K | 0 | |
| Book value per share | 107.54K | 111.23K | 111.56K | 132.4K | 0 | |
| Tangible book value per share | 133.61K | 137.67K | 137.83K | 163.51K | 0 | |
| Share holders equity per share | 107.54K | 111.23K | 111.56K | 132.4K | 0 | |
| Interest debt per share | 35.52K | 37.95K | 52.6K | 61.88K | 0 | |
| Market cap | 796.09B | 717.97B | 665.01B | 528.13B | 0 | |
| Enterprise value | 1211.51B | 1044.87B | 1030.86B | 1019.42B | 0 | |
| P/E ratio | 5.72 | 2.41 | 14.52 | -12.42 | 0 | |
| Price to sales ratio | 1.84 | 1.5 | 1.82 | 1.42 | 0 | |
| POCF ratio | 24.53 | 27.7 | -7.78 | -6.43 | 0 | |
| PFCF ratio | -17.46 | -8.99 | -2.71 | -2.66 | 0 | |
| P/B Ratio | 0.39 | 0.33 | 0.31 | 0.25 | 0 | |
| PTB ratio | 0.39 | 0.33 | 0.31 | 0.25 | 0 | |
| EV to sales | 2.8 | 2.19 | 2.83 | 2.75 | 0 | |
| Enterprise value over EBITDA | 12.41 | 22.73 | 10.53 | 50.22 | 0 | |
| EV to operating cash flow | 37.33 | 40.31 | -12.06 | -12.41 | 0 | |
| EV to free cash flow | -26.56 | -13.09 | -4.19 | -5.13 | 0 | |
| Earnings yield | 0.04 | 0.1 | 0.02 | -0.02 | 0 | |
| Free cash flow yield | -0.06 | -0.11 | -0.37 | -0.38 | 0 | |
| Debt to equity | 0.33 | 0.34 | 0.47 | 0.46 | 0 | |
| Debt to assets | 0.18 | 0.18 | 0.24 | 0.24 | 0 | |
| Net debt to EBITDA | 4.25 | 7.11 | 3.74 | 24.2 | 0 | |
| Current ratio | 2.54 | 2.38 | 2.32 | 3.04 | 2.98 | |
| Interest coverage | 19.62 | 4.09 | -1.45 | -1.55 | 0 | |
| Income quality | 0.77 | 0.31 | -7.47 | 5.31 | 0 | |
| Dividend Yield | 0.01 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0.22 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.02 | 0.01 | 0.24 | 0.02 | 0.18 | |
| Research and developement to revenue | 0.06 | 0.06 | 0.07 | 0.1 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
| Capex to operating cash flow | -2.41 | -4.08 | 1.88 | 1.42 | 0 | |
| Capex to revenue | -0.18 | -0.22 | -0.44 | -0.31 | 0 | |
| Capex to depreciation | -3.4 | -4.45 | -6.46 | -4.08 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 66.27K | 98.2K | 38.66K | 44.37K | 0 | |
| ROIC | 0.02 | 0.01 | 0 | 0 | 0.03 | |
| Return on tangible assets | 0.01 | 0.02 | 0 | 0 | 0.01 | |
| Graham Net | 52.12K | 49.94K | 38.72K | 39.28K | 0 | |
| Working capital | 1546.98B | 1459.87B | 1476.52B | 1602.88B | 1511.36B | |
| Tangible asset value | 2563.11B | 2657.13B | 2648.99B | 2628.72B | 2700.63B | |
| Net current asset value | 1327.31B | 1281.92B | 1087.12B | 989.74B | 860.83B | |
| Invested capital | 0.33 | 0.34 | 0.47 | 0.46 | 0 | |
| Average receivables | 310.8B | 307.57B | 306.41B | 309.16B | 162.35B | |
| Average payables | 131.12B | 118.34B | 102.98B | 95.89B | 40.51B | |
| Average inventory | 471.26B | 498.35B | 499.92B | 524.1B | 265.55B | |
| Days sales outstanding | 61.57 | 60.2 | 72.5 | 78.7 | 0 | |
| Days payables outstanding | 45.61 | 25.85 | 37.4 | 25.89 | 0 | |
| Days of inventory on hand | 165.67 | 131.09 | 174.6 | 169.74 | 0 | |
| Receivables turnover | 1.46 | 1.49 | 1.24 | 1.14 | 0 | |
| Payables turnover | 1.97 | 3.48 | 2.41 | 3.48 | 0 | |
| Inventory turnover | 0.54 | 0.69 | 0.52 | 0.53 | 0 | |
| ROE | 0.02 | 0.03 | 0.01 | 0 | 0.02 | |
| Capex per share | -4.07K | -5.48K | -8.34K | -7.25K | 0 |
28513K.KS Frequently Asked Questions
What is SK Chemicals Co.,Ltd. stock symbol ?
SK Chemicals Co.,Ltd. is a KR stock and trading under the symbol 28513K.KS
What is SK Chemicals Co.,Ltd. stock quote today ?
SK Chemicals Co.,Ltd. stock price is $30350 today.
Is SK Chemicals Co.,Ltd. stock public?
Yes, SK Chemicals Co.,Ltd. is a publicly traded company.
Company Profile
- Volume Average 8.57K
- Market Capitalization 59.61B
- Employee 1.22K
- CEO Mr. Kwang-Hyun Jeon
- Headquarters Seongnam-si,KR
- IPO Date 2018-01-12
-
Website
https://www.skchemicals.com 
SK Chemicals Co., Ltd. provides chemicals and life sciences products and solutions in South Korea and internationally. The company develops copolysters, coating and adhesive materials, engineering plastics, prepergs, bio materials, and 3D printing materials, as well as specialty chemicals, pharmaceutical products, and vaccines. It has a collaborate agreement with Standigm, Inc. to develop an AI-driven drug candidate for non-alcoholic steatohepatitis. The company was founded in 1969 and is headquartered in Seongnam, South Korea.
